 |
Presentations of the ecopa Annual Meeting 2006
Brussels, Sheraton Airport, November 25-26, 2006 |
 |
 |
 |
 |
 |
"Report on eSI, Scientific Plan, 7th Framework Program"
Jose Castell, Vice-president ecopa, ES
|
 |
 |
 |
 |
 |
"Testing Barriers and Transports: New Basis"
Romeo Cecchelli
|
 |
 |
 |
 |
 |
"ecopa Budget"
Bernward Garthoff, Treasurer of ecopa
|
 |
 |
 |
 |
 |
"Test Requirements of REACH on the Long term vs. Basis of New Methodology"
Bernward Garthoff, Treasurer of ecopa, Bayer AG, Leverkusen, D
|
 |
 |
 |
 |
 |
"REACH and current alternative methodological approaches in (pre)validation"
Thomas Hartung & ECVAM Team, Institute for Health and Consumer Protection (IHCP), Ispra (Va), Italy
|
 |
 |
 |
 |
 |
"REACH & EPAA: The way to innovate by dual partnership?"
Colin Humphris
|
 |
 |
 |
 |
 |
"The Innovative Medicines Initiative: Implications for the Development of 3R-Alternatives"
C. Ian Ragan, European Scientfic Affairs, Ei Lilly and EFPIA Research Directors Group
|
 |
 |
 |
 |
 |
"Outcome of the 6th FP Projects, help for REACH?"
Vera Rogiers, Chair of ecopa, Dept. of Toxicology, Vrije Universiteit Brussel, BE
|
 |
 |
 |
 |
 |
"Initiatives taken and further acitvities"
Vera Rogiers, Chair of ecopa, Dept. of Toxicology, Vrije Universiteit Brussel, BE
|
 |
 |
 |
 |
 |
"REACH and epaa: the way to innovate by dual Partnership? The view from outside: Academia"
H. Seibert, Institute of Toxicology and Pharmacology for Natural Scientist, University Medical School Schleswig-Holstein, Campus Kiel, Germany
|
 |
 |
 |
 |
 |
"Does Norway need ecopa? Do we need a National Consensus Platform in Norway? What are we doing in Norway?"
Adrian Smith, Norwegian School of Veterinary Science
|
 |
 |
 |
 |
 |
"REACH and alternative testing: the REACH information requirements and the perspectives to use alternatives to animal experimentation"
Katinka van der Jagt, DG ENTR / G1 - REACH
|
 |
 |
 |
 |
 |
"Partnership"
Jan van der Valk
|
 |
 |
 |
 |
 |
"Development of a custom-made microarray as an alternative tool for screening of endrocine disruptors"
Caroline Vanparys, Marleen Maras, Karlijn van der Ven, Johan Robbens, Ronny Blust, Wim de Coen, University of Antwerp, Belgium
|
 |
 |
 |
 |
 |
"Impact of REACH on Animal Use"
Simon Webb
|
 |
 |
 |
 |
 |
"Characterization of a renal cell model by gene expression analysis"
Christina Weiland, Molecular and Special Toxicology, Bayer Healthcare AG
|
 |
 |
 |
|
 |
|